The burden attributable to substance use in the Russian Federation

Cover Page

Cite item

Full Text

Abstract

Aim. Assessment of the health consequences of substance use in the form of lost years of healthy life in the world in comparison with Russia. An additional task was to determine the economic losses from alcohol, tobacco and drugs in the Russian Federation.

Methods. We used indicators of mortality, morbidity, prevalence, and years of life lost, taking into account the DALY disability from tobacco, alcohol, opiates, cannabis, and other drugs (ICD10: I42.6, K70.03, Z72.0, F10-19). Indicators of harmful health effects from PS were presented from 1990 to 2017. Variables were standardized by age and sex. An economic assessment of the impact of tobacco, alcohol, and drugs denominated in rubles was applied.

Results. Total economic losses from psychoactive substances, expressed in rubles, amounted to from 887.4 billion to 8.5 trillion rubles in Russia in 2017. The greatest harmful effects on health from psychoactive substances in Russia and the world are caused by tobacco, with alcohol in the second place. The damage from smoking in Russia in years of lost life including disability DALY amounted to 8.6 million in 2017 Alcohol consumption and its consequences in Russia caused 1.85 million DALYs of harm to health, alcoholic cirrhosis and other liver diseases-643 thousand DALYs.

Conclusion. Alcohol and nicotine cause maximum harm to the health and economy of Russia, and in conditions of limited resources, the main efforts should be directed at preventing the consequences of alcoholism and tobacco smoking.

About the authors

Sergej S. Soshnikov

Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Email: s.soshnikov@yahoo.com
Russian Federation, 127254, Moscow, Dobrolubov str., 11

Vladimir I. Starodubov

Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Email: s.soshnikov@yahoo.com
Russian Federation, 127254, Moscow, Dobrolubov str., 11

Dar’ya A. Khaltourina

Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Email: s.soshnikov@yahoo.com
Russian Federation, 127254, Moscow, Dobrolubov str., 11

Vasilij V. Vlassov

National Research University Higher School of Economics

Email: vvvlas@gmail.com
Russian Federation, 109028, Moscow, Pokrovski Blvd, 11

Ol’ga V. Obuhova

Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Email: bidrisov@gmail.com
Russian Federation, 127254, Moscow, Dobrolubov str., 11

Bulat T. Idrisov

Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation; Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry for Healthcare of the Russian Federation

Author for correspondence.
Email: bidrisov@gmail.com
Russian Federation, 127254, Moscow, Dobrolubov str., 11; 50008, Ufa, Lenin str., 3

References

  1. Degenhardt L., Charlson F., Ferrari A. et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018; 5 (12): 987–1012.
  2. Griswold M.G., Fullman N., Hawley C. et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018; 392 (10 152): 1015–1035.
  3. James S.L., Abate D., Abate K.H. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392 (10 159): 1789–1858.
  4. Kyu H.H., Abate D., Abate K.H. et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392 (10 159): 1859–1922.
  5. Roth G.A., Abate D., Abate K.H. et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392 (10 159): 1736–1788.
  6. GBD, Global Burden of Diseases study protocol. Version 3.0; Issued 26 February 2018. Institute for Health Metrics and Evaluation. http://www.healthdata.org/gbd/about/protocol (access date: 01.03.2020).
  7. WHO. Metrics: Disability-Adjusted Life Year (DALY). 2019. https://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/ (access date: 01.03.2020).
  8. Могилевская А. За год «стоимость» жизни россиян выросла на 1 млн руб. Росбизнесконсалтинг. https://www.rbc.ru/economics/27/06/2017/59523d3c9a7947d75f8792bf (дата об- ращения: 01.03.2020).
  9. Зубец А. «Стоимость» человеческой жизни в России с учётом морального ущерба в начале 2018 года поднялась до 46,9 млн рублей. Исследование Финансового университета при Правительстве РФ. http://www.fa.ru/org/div/cos/press/Documents/58_Life_Value_2018.pdf (дата обращения: 01.03.2020).
  10. Archie S.R., Cucullo L. Harmful effects of smoking cannabis: A cerebrovascular and neurological perspective. Front. Pharmacol. 2019; 10: 1481.
  11. Aebi M.F., Hashimoto Y.Z., Tiago M.M. Probation and Prisons in Europe, 2018: Key findings of the SPACE reports. http://wp.unil.ch/space/files/2019/05/Key-Findings_SPACE-II_190520-1.pdf (access date: 01.03.2020).
  12. Антонян Ю.М., Бражников Д.А., Гончарова М.В. и др. Комплексный анализ состояния преступности в Российской Федерации и расчётные варианты её развития. ФГКУ «ВНИИ МВД России». 2018. https://mvd.ru/upload/site163/document_text/Kompleksnyy_analiz__original-maket_24_04.pdf (дата обращения: 01.03.2020).

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The incidence of disorders caused by the use of psychoactive substances in 1990–2017, both sexes, per 100 thousand of the population. The detailed data described above can be found at: http://ihmeuw.org/51c6

Download (72KB)
3. Fig. 2. The prevalence of disorders caused by the use of psychoactive substances in 1990–2017, both sexes, per 100 thousand people. The detailed data described above can be found at: http://ihmeuw.org/51bz

Download (79KB)
4. Fig. 3. Mortality from disorders associated with the use of psychoactive substances in 1990–2017, per 100 thousand people. The detailed data described above can be found at: http://ihmeuw.org/51c0

Download (95KB)

Copyright (c) 2020 Soshnikov S.S., Starodubov V.I., Khaltourina D.A., Vlassov V.V., Obuhova O.V., Idrisov B.T.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies